[
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors despite losses on the day",
    "summary": "AbbVie Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=24c095e135f5aaf64a3a3cf12a4de4dce362e1e1151b05482b3cd5ef81a19d79",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733416440,
      "headline": "AbbVie Inc. stock outperforms competitors despite losses on the day",
      "id": 131874388,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=24c095e135f5aaf64a3a3cf12a4de4dce362e1e1151b05482b3cd5ef81a19d79"
    }
  },
  {
    "ts": null,
    "headline": "How To Put $100 In Your Retirement Fund Each Month With AbbVie Stock",
    "summary": "AbbVie Inc. (NYSE:ABBV) discovers, develops, manufactures and sells pharmaceuticals worldwide. It will report its Q4 2024 earnings on Jan. 31, 2025. Wall Street analysts expect the company to post an EPS of $2.98, up from $2.79 in the year-ago period. ...",
    "url": "https://finnhub.io/api/news?id=a5d337c9d0998a2f87398607f8d0d268d430bbbc45dcf74af1a170272fe06c92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733407215,
      "headline": "How To Put $100 In Your Retirement Fund Each Month With AbbVie Stock",
      "id": 131796676,
      "image": "https://media.zenfs.com/en/benzinga_79/9ec045fa2a742facdb7673bdbc9d2c4d",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie Inc. (NYSE:ABBV) discovers, develops, manufactures and sells pharmaceuticals worldwide. It will report its Q4 2024 earnings on Jan. 31, 2025. Wall Street analysts expect the company to post an EPS of $2.98, up from $2.79 in the year-ago period. ...",
      "url": "https://finnhub.io/api/news?id=a5d337c9d0998a2f87398607f8d0d268d430bbbc45dcf74af1a170272fe06c92"
    }
  },
  {
    "ts": null,
    "headline": "Columbia Dividend Opportunity Fund Q3 2024 Commentary",
    "summary": "Institutional Class shares of Columbia Dividend Opportunity Fund returned 9.51% for the \nthird quarter. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=e4db43d07b7e4e8068187a3bf164970512789db26f6e7a3289ddcfb4a5000d38",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733357700,
      "headline": "Columbia Dividend Opportunity Fund Q3 2024 Commentary",
      "id": 131773941,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1283813790/image_1283813790.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Institutional Class shares of Columbia Dividend Opportunity Fund returned 9.51% for the \nthird quarter. Click here to read the full commentary. \n",
      "url": "https://finnhub.io/api/news?id=e4db43d07b7e4e8068187a3bf164970512789db26f6e7a3289ddcfb4a5000d38"
    }
  }
]